Modulation of endothelin-1 effects on rat hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 2, 1996, Pages 265-277

  Ebihara, Yoshinori ^a   Haist, James V ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cardiac myocytes; Contracture; Endothelin; Intracellular calcium; Left ventricular end diastolic pressure; Nitric oxide

Indexed keywords

8 BROMO CYCLIC GMP; ARGININE METHYL ESTER; CALCIUM ION; CYCLIC GMP; ENDOTHELIN 1; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CARDIOTOXICITY; CONTROLLED STUDY; DIASTOLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE FIBRILLATION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLE;

ANIMALIA;

EID: 0029971269     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0025     Document Type: Article

References (44)

1. BALLIGAND J-C, UNGUREANU-LONGROIS D, SIMMONS WW, PIMENTAL D, MALINSKI TA, KAPTURCZAK M, TAHA Z, LOWENSTEIN CJ, DAVIDOFF AJ, KELLY RA, SMITH TW, MICHEL T, 1994. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269: 27580-27588.
2. BAYDOUN AR, PEERS SH, CIRINO G, WOODWARD B, 1989. Effects of endothelin-1 on the rat isolated heart. J Cardiovasc Pharmacol 13 [Suppl. 5]: S193-S196.
3. BOULANGER C, LUSCHER TF, 1990. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587-590.
4. BRADY AJB, WARREN JB, POOLE-WILSON PA, WILLIAMS TJ, HARDING SE, 1993. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182.
5. DUDEK RR, WILDHIRT S, CONFORTO A, PINTO V, SUZUKI H, WINDER S, BING RJ, 1994. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun 205: 1671-1680.
6. FIRTH JD, ROBERTS AFC, RAINE AEG, 1990. Effect of endothelin on the function of the isolated perfused working rat heart. Clin Sci 79: 221-226.
7. GROCOTT-MASON R, FORT S, LEWIS MJ, SHAH AM, 1994. Myocardial relaxant effect of exogenous nitric oxide in isolated ejecting hearts. Am J Physiol 266: H1699-H1705.
8. HAYASHIDA W, DONCKIER J, VAN MECHELEN H, STOLERU L, POULEUR H, 1993. Endothelin-1 exacerbates diastolic stunning in conscious dogs. Am J Physiol 265: H1688-H1695.
9. HAYNES WG, WEBB DJ, 1993. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 84: 485-500.
10. IGNARRO LJ, BUGA GM, WOOD KS, BYRNS RE, CHAUDHURI G, 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269.
11. ISHIKAWA T, LI L, SHINMI O, KIMURA S, YANAGISAWA M, GOTO K, MASAKI T, 1991. Characteristics of binding of endothelin-1 and endothelin-3 to rat hearts: developmental changes in mechanical responses and receptor subtypes. Circ Res 69: 918-926.
12. KAGAMU H, SUZUKI T, ARAKAWA M, MITSUI Y, 1994. Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes. Biochem Biophys Res Commun 202: 1612-1618.
13. KARWATOWSKA-PROKOPCZUK E, WENNMALM A, 1990. Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. Circ Res 66: 46-54.
14. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts. Circ Res 75: 369-378.
15. + exchanger. Circ Res 68: 269-279.
16. 2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes. J Physiol 448: 729-747.
17. LECHLEITNER P, GENSER N, MAIR J, MAIER J, ARTNER-DWORZAK E, DIENTSL F, PUSCHENDORF B, 1993. Plasma immunoreactive endothelin in acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis. Clin Chem 39: 955-959.
18. LI K, STEWART DJ, ROULEAU J-L, 1991. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Role of endocardial endothelium. Circ Res 69: 301-312.
19. MALATINO L, GRASSI R, STANCANELLI B, POLIZZI G, LEONARDI C, TAMBURINO C, TAMBURINO G, 1993. Release of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplasty. Am Heart J 126: 700-702.
20. MASAKI T, 1993. Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrine Rev 14: 256-268.
21. MIYAUCHI T, YANAGISAWA M, TOMIZAWA T, SUGISHITA Y, SUZUKI N, FUJINO M, AJISAKA R, GOTO K, MASAKI T, 1989. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2: 53-54.
22. MEBAZAA A, MAYOUX E, MAEDA K, MARTIN LD, LAKATTA EG, ROBOTHAM JL, SHAH AM, 1993. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol 265: H1841-H1846.
23. MCCLELLAN G, WEISBERG A, ROSE S, WINEGRAD S, 1994. Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ Res 75: 85-96.
24. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88: 1197-1201.
25. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterase through guanylyl cyclase activation. J Biol Chem 268: 26286-26295.
26. NAMIKI A, HIRATA Y, FUKAZAWA M, ISHIKAWA M, MOROI M, AIKAWA J, YABUKI S, MACHII K, 1992. Endothelin 1 and endothelin 3 induced vasorelaxation via endothelium derived nitric oxide. Jpn J Pharmacol 58 [Suppl. 2]: 326P.
27. O'MURCH B, MILLER VM, PERRELLA MA, BURNETT JR JC, 1994. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest 93: 165-171.
28. A receptors in guinea pig atria. Circ Res 76: 284-292.
29. PALMER RMJ, FERRIGE AG, MONCADA S, 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
30. PAULUS WJ, VANTRIMPONT PJ, SHAH AM, 1994. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89: 2070-2078.
31. 2+ and contractility in single ventricular myocytes from the ferret and human. Eur J Pharmacol 214: 293-296.
32. RAMACIOTTI C, MCCLELLAN G, SHARKEY A, ROSE D, WEISBERG A, WINEGRAD S, 1993. Cardiac endothelial cells modulate contractility of rat heart in response to oxygen tension and coronary flow. Circ Res 72: 1044-1064.
33. RAY SG, MCMURRAY JJ, MORTON JJ, DARGIE HJ, 1992. Circulating endothelin in acute ischaemic syndromes. Br Heart J 67: 383-386.
34. RUBANYI GM, POLOKOFF MA, 1994. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415.
35. 2+ in intact cardiac myocytes. Circ Res 74: 970-978.
36. SUZUKI T, KUMAZAKI T, MITSUI Y, 1993. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191: 823-830.
37. TAKANASHI M, ENDOH M, 1991. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261: H611-H619.
38. WAHLER GM, DOLLINGER SJ, 1995. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol 268: C45-C54.
39. 2+ responsiveness in acquorin-loaded ferret myocardium. Circ Res 69: 582-589.
40. WARNER TD, MITCHELL JA, DE NUCCI G, VANE JR, 1989. Endothelin 1 and 3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 13 [Suppl. 5]: S85-S88.
41. WILDHIRT SM, DUDEK RR, SUZUKI H, PINTO V, NARAYAN KS, BING RJ, 1995. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res 29: 526-531.
42. WINLAW DS, SMYTHE GA, KEOGH AM, SCHYVENS CG, SPRATT PM, MACDONALD PS, 1994. Increased nitric oxide production in heart failure. Lancet 344: 373-374.
43. i elevation in the rat cardiomyocyte. Br J Pharmacol 108: 6-8.
44. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T, 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.